AUTOPHAGY BIOMARKERS SQSTM1/P62 AND BECLIN-1 EXPRESSION IN BREAST CARCINOMA AND THEIR CLINICOPATHOLOGICAL SIGNIFICANCE.
- Department of Pathology, Faculty of Medicine, Beni-Suef University, Egypt.
12 Downloads
120 Views
Abstract
Background: Clarifying the different mechanisms of molecular carcinogenesis of breast carcinoma could enable its better management, improving its prognosis and decreasing patient?s mortality. Autophagy is the process of lysosomal degradation which could remove the damaged components so as to preserve cells homeostasis. Autophagy had a complicated role in cancer as it might inhibit or stimulate cancer progression which depend on the type of cancer. Several proteins which control autophagy had been discovered in human cells such as Beclin-1and SQSTM1/p62 (Sequestosome-1) that played important roles in autophagy.
Aim of the work: This study aimed to assess expressions of autophagy markers SQSTM1/p62 and Beclin-1 in breast carcinoma comparing expression of both markers with clinicopathological parameters of that type of cancer.
Patients and methods: SQSTM1/p62, Beclin-1 expression was evaluated using immunohistochemistry on sixty paraffin blocks of breast carcinoma. Then correlations between their expression levels and clinicopathological parameters were done.
Results: SQSTM1-p62 overexpression in breast carcinoma was strongly related to higher grade (=0.002) and American Joint Committee on Cancer staging system (AJCC stage) of the tumor, aggressive molecular type (=0.009), presence of lymph node metastases (=0.041), high KI67 index (p<0.001), negative ER& PR hormonal receptors (=0.01), Her2 neu expression (=0.03), presence of distant metastasis (p=0.011). The sensitivity of p62 over-expression as a predictor for advanced stage of breast carcinoma was 72.4 and the specificity was 97.9. Beclin-1 low expression was significantly correlated with aggressive molecular type (=0.004), higher grade (p<0.001) and AJCC stage of the tumor (p=0.002), presence of lymph node metastases (=0.041), high KI67 index (p<0.001), negative ER& PR hormonal receptors (=0.003), high Her2 neu expression (=0.006), presence of distant metastasis (p=0.011). But it had no significant correlation with histopathological subtype of breast cancer. The sensitivity of low Beclin-1 expression as a predictor For advanced stage of breast carcinoma was 85.5 and the specificity was 97.9. We found an inverse relationship between p62 and Beclin-1 (Spearman?s r= ? 0.806),
Conclusion: SQSTM1-p62 over expression is a marker of poor prognosis, but Beclin-1 overexpression was a marker of good prognosis in breast carcinoma.
Keywords
How to Cite This Article
Dina A. Khairy and Abla S. Mahmoud. (2018); AUTOPHAGY BIOMARKERS SQSTM1/P62 AND BECLIN-1 EXPRESSION IN BREAST CARCINOMA AND THEIR CLINICOPATHOLOGICAL SIGNIFICANCE., International Journal of Advanced Research (IJAR), 6 (02), 1846-1856, ISSN 2320-5407. DOI: https://doi.org/10.21474/IJAR01/6627
Corresponding Author
Article Analytics
References
1. Siegel R, Ma J, Zou Z, Jemal A (2014). Cancer statistics. CA: A Cancer J Clin 64:9?29.
2. Mokhtar N, Gouda I and Adel I (2007); - pathology registry 2003-2004 Department of pathology, NCI.
3. Jemal A, Center MM, DeSantis C, Ward EM (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 19:1893?1907.
4. Young AR, Narita M, Ferreira M, Kirschner K, Sadaie M, Darot JF, et al (2009). Autophagy mediates the mitotic senescence transition. Genes Dev 23: 798?803.
5. Mathew R,White E (2011). Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night. Curr Opin Genet Dev 21:113?119.
6. White E (2012). Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 12:401?410.
7. Weidberg H, Shvets E, Elazar Z (2011). Biogenesis and cargo selectivity of autophagosomes. Annu Rev Biochem 80:125?156.
8. Cao Y, Klionsky DJ (2007). Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein. Cell Res 17:839?849.
9. Kondo Y, Kanzawa T, Sawaya R, Kondo S (2005). The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 5:726?734.
10. Lamark T, Kirkin V, Dikic I, Johansen T (2009). NBR1 and p62 as cargo receptors for selective autophagy of ubiquitinated targets. Cell Cycle 8:1986?1990.
11. Edge SB, Compton CC (2010). The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471?1474.
12. Elston CW (2002). Pathological prognostic factors in breast cancer I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19:403?410.
13. Hsu SM, Raine L, Fanger H (1981). Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577?580.
14. Won KY, Kim GY, Kim YW, Song JY, Lim SJ (2010). Clinicopathologic correlation of beclin-1 and bcl-2 expression in human breast cancer. Hum Pathol 41:107?112.
15. Chen Y, Li X, Wu X, He C, Guo L, Zhang S, et al (2013). Autophagy-related proteins LC3 and Beclin-1 impact the efficacy of chemoradiation on esophageal squamous cell carcinoma. Pathol Res Pract 209:562?567.
16. Luo RZ, Yuan ZY, Li M, Xi SY, Fu J, He J (2013). Accumulation of p62 is associated with poor prognosis in patients with triple-negative breast cancer. Onco Targets Ther 6:883?888.
17. Jiang L, Huang S, Li W, Zhang D, Zhang S, Zhang W, et al (2012). Expression of autophagy and ER stress-related proteins in primary salivary adenoid cystic carcinoma. Pathol Res Pract 208:635?641.
18. Sakakura K, Takahashi H, Kaira K, Toyoda M, Oyama T, Chikamatsu K (2015). Immunological significance of the accumulation of autophagy components in oral squamous cell carcinoma. Cancer Sci 106:1?8.
19. Dong M,Wan XB, Yuan ZY,Wei L, Fan XJ,Wang TT, et al (2013). Low expression of Beclin 1 and elevated expression of HIF-1a refine distant metastasis risk and predict poor prognosis of ER-positive, HER2-negative breast cancer. Med Oncol 30:355.
20. He Y, Zhao X, Subahan NR, Fan L, Gao J, Chen H (2014). The prognostic value of autophagy-related markers beclin-1 and microtubule-associated protein light chain 3B in cancers: a systematic review and meta-analysis. Tumour Biol 35:7317?7326.
21. Ahn CH, Jeong EG, Lee JW, Kim MS, Kim SH, Kim SS, et al (2007). Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers. APMIS 115:pp. 1344?1349.
22. Qiu DM,Wang GL, Chen L, Xu YY, He S, Cao XL, et al (2014). The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance. BMC Cancer 14:327.
23. Han Y, Xue XF, Shen HG, Guo XB, Wang X, Yuan B, et al (2014). Prognostic significance of Beclin-1 expression in colorectal cancer: a meta-analysis. Asian Pac J Cancer Prev 15:4583?4587.
24. Koukourakis MI, Giatromanolaki A, Sivridis E, Pitiakoudis M, Gatter KC, Harris AL (2010). Beclin 1 over- and under-expression in colorectal cancer: distinct patterns relate to prognosis and tumor hypoxia. Br J Cancer 103:1209?1214.
25. Samokhvalov V, Scott BA, Crowder CM (2008). Autophagy protects against hypoxic injury in C. elegans. Autophagy 4:1034?1041.
26. Mathew R, Kongara S, Beaudoin B, Karp CM, Bray K, Degenhardt K, et al (2007). Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev 21:1367?1381.
27. Xu Y, Liu XD, Gong X, Eissa NT (2008). Signaling pathway of autophagy associated with innate immunity. Autophagy 4:110?112.
Similar Articles
8
122
1
27
3
90
3
96
1
91
This work is licensed under a Creative Commons Attribution 4.0 International License.